Literature DB >> 15923465

Toward a comprehensive long term nicotine policy.

N Gray1, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, P Boyle.   

Abstract

Global tobacco deaths are high and rising. Tobacco use is primarily driven by nicotine addiction. Overall tobacco control policy is relatively well agreed upon but a long term nicotine policy has been less well considered and requires further debate. Reaching consensus is important because a nicotine policy is integral to the target of reducing tobacco caused disease, and the contentious issues need to be resolved before the necessary political changes can be sought. A long term and comprehensive nicotine policy is proposed here. It envisages both reducing the attractiveness and addictiveness of existing tobacco based nicotine delivery systems as well as providing alternative sources of acceptable clean nicotine as competition for tobacco. Clean nicotine is defined as nicotine free enough of tobacco toxicants to pass regulatory approval. A three phase policy is proposed. The initial phase requires regulatory capture of cigarette and smoke constituents liberalising the market for clean nicotine; regulating all nicotine sources from the same agency; and research into nicotine absorption and the role of tobacco additives in this process. The second phase anticipates clean nicotine overtaking tobacco as the primary source of the drug (facilitated by use of regulatory and taxation measures); simplification of tobacco products by limitation of additives which make tobacco attractive and easier to smoke (but tobacco would still be able to provide a satisfying dose of nicotine). The third phase includes a progressive reduction in the nicotine content of cigarettes, with clean nicotine freely available to take the place of tobacco as society's main nicotine source.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923465      PMCID: PMC1748036          DOI: 10.1136/tc.2004.010272

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  33 in total

1.  Doses of nicotine and lung carcinogens delivered to cigarette smokers.

Authors:  M V Djordjevic; S D Stellman; E Zang
Journal:  J Natl Cancer Inst       Date:  2000-01-19       Impact factor: 13.506

2.  Variation within global cigarette brands in tar, nicotine, and certain nitrosamines: analytic study.

Authors:  N Gray; D Zaridze; C Robertson; L Krivosheeva; N Sigacheva; P Boyle
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

Review 3.  Cigarette filter ventilation is a defective design because of misleading taste, bigger puffs, and blocked vents.

Authors:  L T Kozlowski; R J O'Connor
Journal:  Tob Control       Date:  2002-03       Impact factor: 7.552

4.  A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches.

Authors:  R V Fant; J E Henningfield; S Shiffman; K R Strahs; D P Reitberg
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

Review 5.  A global approach to tobacco policy.

Authors:  Nigel Gray
Journal:  Lung Cancer       Date:  2003-02       Impact factor: 5.705

6.  Persistent use of nicotine replacement therapy: an analysis of actual purchase patterns in a population based sample.

Authors:  S Shiffman; J R Hughes; J L Pillitteri; S L Burton
Journal:  Tob Control       Date:  2003-09       Impact factor: 7.552

7.  The future of the nicotine-addiction market.

Authors:  Nigel Gray; Peter Boyle
Journal:  Lancet       Date:  2003-09-13       Impact factor: 79.321

Review 8.  Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report.

Authors:  D Balfour; N Benowitz; K Fagerström; M Kunze; U Keil
Journal:  Eur Heart J       Date:  2000-03       Impact factor: 29.983

9.  Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey.

Authors:  M J Jarvis; R Boreham; P Primatesta; C Feyerabend; A Bryant
Journal:  J Natl Cancer Inst       Date:  2001-01-17       Impact factor: 13.506

10.  Cigar smoking in men and risk of death from tobacco-related cancers.

Authors:  J A Shapiro; E J Jacobs; M J Thun
Journal:  J Natl Cancer Inst       Date:  2000-02-16       Impact factor: 13.506

View more
  34 in total

1.  The future of tobacco regulation: a response to a proposal for fundamental institutional change.

Authors:  Jonathan Liberman
Journal:  Tob Control       Date:  2006-08       Impact factor: 7.552

Review 2.  Angiogenesis and the role of the endothelial nicotinic acetylcholine receptor.

Authors:  John P Cooke
Journal:  Life Sci       Date:  2007-02-17       Impact factor: 5.037

Review 3.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

4.  DECOY: Documenting Experiences with Cigarettes and Other Tobacco in Young Adults.

Authors:  Carla J Berg; Regine Haardörfer; Michael Lewis; Betelihem Getachew; Steven A Lloyd; Sarah Fretti Thomas; Angela Lanier; Kelleigh Trepanier; Teresa Johnston; Linda Grimsley; Bruce Foster; Stephanie Benson; Alicia Smith; Dana Boyd Barr; Michael Windle
Journal:  Am J Health Behav       Date:  2016-05

5.  Perceived harm, addictiveness, and social acceptability of tobacco products and marijuana among young adults: marijuana, hookah, and electronic cigarettes win.

Authors:  Carla J Berg; Erin Stratton; Gillian L Schauer; Michael Lewis; Yanwen Wang; Michael Windle; Michelle Kegler
Journal:  Subst Use Misuse       Date:  2014-09-30       Impact factor: 2.164

6.  Dose-response effects of spectrum research cigarettes.

Authors:  Dorothy K Hatsukami; Stephen J Heishman; Rachel Isaksson Vogel; Rachel L Denlinger; Astia N Roper-Batker; Kristen M Mackowick; Joni Jensen; Sharon E Murphy; Brian F Thomas; Eric Donny
Journal:  Nicotine Tob Res       Date:  2012-11-22       Impact factor: 4.244

7.  Cigarette users' interest in using or switching to electronic nicotine delivery systems for smokeless tobacco for harm reduction, cessation, or novelty: a cross-sectional survey of US adults.

Authors:  Carla J Berg; Regine Haardoerfer; Cam Escoffery; Pinpin Zheng; Michelle Kegler
Journal:  Nicotine Tob Res       Date:  2014-06-20       Impact factor: 4.244

Review 8.  Non-cigarette tobacco products: what have we learnt and where are we headed?

Authors:  Richard J O'Connor
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

Review 9.  Research required for the effective implementation of the framework convention on tobacco control, articles 9 and 10.

Authors:  Nigel Gray; Ron Borland
Journal:  Nicotine Tob Res       Date:  2012-09-27       Impact factor: 4.244

Review 10.  Clinical trials methods for evaluation of potential reduced exposure products.

Authors:  Dorothy K Hatsukami; Karen Hanson; Anna Briggs; Mark Parascandola; Jeanine M Genkinger; Richard O'Connor; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.